Models of Care (MoCs) are increasingly recognised as a system-level enabler to translate evidence for 'what works' into policy and, ultimately, clinical practice.
Introduction
The burden of disease of musculoskeletal conditions is a global priority.
The burden of disease of musculoskeletal (MSK) conditions at a global level is well established, evidenced most recently through the Global Burden of Disease (GBD) studies where the disability burden attributed to MSK conditions was observed to be enormous; exceeding all non-communicable diseases (NCDs) other than mental health and behavioural disorders [1, 2] . These data point to the upward trajectory of prevalence and escalating personal and societal impacts of MSK conditions and persistent pain across the life course, further reinforced by recent nation-specific whitepapers and seminal reports [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Against a background of significantly reduced quality of life, function and mental wellbeing, a major human capital consequence of impaired MSK health, is reduced workforce participation and early retirement [7, 15, 16] . Reduced participation has significant downstream consequences for retirement wealth for the individual, and upstream consequences for government, such as reduced taxation revenue and increased welfare payments in many nations [7] . In the context of low and middle-income economies and subsistence communities, MSK-related disability results in reduced capacity for work participation and therefore a critical threat to livelihoods. Importantly, while communicable diseases remain a large driver to disability-adjusted life years in low and middle income economies, the recent GBD data point to an increasing burden of NCDs, particularly MSK conditions, in low and middle-economies [17, 18] . In this context, addressing the burden of disease for MSK conditions across economies and across the life course, and their unifying feature of persistent or recurrent pain, is 4 indeed an urgent global priority [19] . Lim et al (Chapter 3) explore the burden of disease challenges in low and middle-income Asian economies.
The scale of the MSK burden and its sequelae present major challenges to which nations need to adequately respond. While the World Health Organisation (WHO) has developed an guide for nations to assess their policy and program capacity to respond to NCDs, the guide considers only cancer, lung diseases, diabetes and cardiovascular disease [20] . Similarly, the WHO 2013-2020 Global Action Plan for the Prevention and Control of Non-Communicable Diseases [21] focuses on cardiovascular diseases, cancer, chronic respiratory diseases and diabetes; although MSK conditions remain within its scope. Support for nations to develop and sustainably implement system response capacity is needed. This issue of the Journal tackles these challenges across different economic and care settings to provide readers with evidence-informed, practical guidance.
Big problems need big solutions MSK health outcomes are influenced by a range of factors: health system and public health factors (macro-level), service delivery factors (meso-level) and clinician and consumer behaviours (micro-level) [19] (Table 1) . These factors are discussed in further detail across the various chapters in this issue of the Journal. Despite a large volume of evidence for 'what works' to address MSK health impairments and their sequelae, these evidence-based strategies are inadequately applied in practice by health providers [22] [23] [24] [25] , inadequately integrated into lifestyle behaviours by health 5 consumers [26] [27] [28] , and feature in health policy and health service delivery objectives at a level grossly incommensurate with the burden of disease [29] [30] [31] [32] [33] . In order to effectively and sustainably address the burden of disease of MSK conditions, a multi-level response is required, where macro, meso, and micro-level factors need to be considered [19] . As outlined in the various chapters in this issue of the Journal, a multi-level response is necessarily a complex intervention that demands a cross-sector, multidisciplinary and a partnerships-driven approach, 
Models of Care for musculoskeletal health
What are they?
A MoC is an evidence-informed policy or framework that outlines the optimal manner in which condition-specific care should be made available and delivered to consumers at a systems level. A MoC aims to describe the principles of care for a given condition (the 'what'), as well as guidance on how those principles could be implemented in a local setting (the 'how'). MoCs aim to address current and projected community need in the context of local operational requirements. The guidance provided is coined as "the right care, delivered at the right time, by the right team, in the right place, with the right resources" [34] . MoCs are used as a facilitator to bridge the gap between evidence for what works (or doesn't work) in care delivery and practice, by describing not only what to do, but critically also how to do it within a health system, considering the macro, meso and micro levels. Here, 6 an important distinction is that a MoC is not a clinical practice guideline. Rather, MoCs complement clinical practice guidelines by serving as a guide to describe how best-evidence for delivery of MSK care can be implemented as a sector-wide model of service delivery by clinicians, consumers, and health systems across the disease continuum, while considering practicalities of the local environment. A Model of Service Delivery is not the same as a MoC. A Model of Service Delivery operationalizes the MoC and describes in detail how a given MoC is to be implemented in a local setting or health service at an operational level. A Model of Service Delivery is therefore the next step in the implementation continuum ( Figure   1 ).
Figure 1
Schematic of the continuum between identifying a complex health problem to implementing best practice care within a local setting. [38] .
The diversity and scope of the stakeholders involved will vary according to the clinical issue being addressed and will be further informed by how the local health system operates, and related political considerations. In Australia, for example, a centrally-coordinated Health Network model is used in some jurisdictions [34] , with established effectiveness [39, 40] . Critically, given the increasing global attention towards the development and implementation of MoCs, there is a need to apply some level of standardisation to the development, implementation and evaluation [52] . In this context, in order to achieve improved MSK health outcomes outside research settings, a better understanding of the 'how' to deliver MSK healthcare services and align evidence with policy and practice is required.
While MoCs provide guidance on how the right care should be delivered to people with MSK health conditions, further guidance on various implementation approaches to achieve such system-wide care delivery reforms and sustainability in local models of service delivery is needed. This issue of the Journal is devoted to this topic. In this chapter we provide an overview of the implementation approaches used across care settings, ages and conditions. implementation and evaluation components) [61, 62] .
To ensure sustainability of these initiatives, local "champions" of MSK MoC implementation are required, consistent with the approach in high-income settings.
These could include individuals involved in the education and mentoring of trainees, as well as those involved in research to develop a research agenda appropriate to local conditions.
Building capacity to support implementation of Models of Care
Two priority foci of building capacity to support implementation of MoCs are consumer involvement and an appropriately skilled health workforce. A key lever to support both these foci is the use of digital technologies which can reach across care settings and bypass care disparities imposed by geography, sociocultural factors and economies. Such technologies therefore play a very important role in supporting system-wide implementation.
Consumer involvement
Harnessing consumer involvement to support implementation is an intuitive corollary of actively engaging consumers in the development of MoCs. This involvement extends to decisions about their care, how health services and systems 16 are designed, and delivered to empower consumers and achieve improved health outcomes, all factors consistent with WHO recommendations for consumer-centred healthcare [63] .
In Chapter 4 of this edition, Walsh and colleagues specifically tackle the 'how to' harness consumer involvement and present an elegant evidence-synthesis and commentary relevant across health system levels (macro, meso and micro) [64] .
Walsh and colleagues report that the current available evidence is primarily focused at the micro level and typically of a lower quality, with evidence lacking at the mesoand macro-levels. While they advocate 'no one size fits all' for adopting consumer involvement in MoCs, various options are presented to show how these may be adapted for use in low-and middle-income economies, or best suit high-income economies.
Consumer involvement strategies can extend from representation on MoC working groups, to stakeholder forums, workshops, and opportunities to provide feedback on [58] .
Harnessing eHealth technologies to build capacity
EHealth is a part of the contemporary health landscape and is a critical enabler to implementation of accessible, sustainable and integrated MSK MoCs. Based on findings of the third global survey on eHealth 2015, the Atlas of eHealth country profiles has been developed to provide a snapshot of member states capacity to implement eHealth systems [71] . The use of eHealth as a mechanism to support implementation of MoCs is intuitive, given the capacity to up-scale effective technologies, to lever system and economic efficiencies, to contribute to sustainability, to adapt to low-resource settings and to mitigate access and care This initiative uses a suite of software tools specifically designed to work in lowbandwidth, low-infrastructure settings, to provide eLearning/mLearning distance education and tele-expertise consultations. This eHealth solution is suitable for rural, primary, secondary and tertiary care settings and has been implemented in areas of Africa, Bolivia and Laos.
For consumers, eHealth systems offer implementation support for MoC through a wide range of eHealth applications that aim to provide health information plus social support, decision support, and behaviour change support [74, 78] . In Chapter 7,
Slater and colleagues demonstrate how advances in technologies have enabled realtime mobility and movement monitoring in natural settings [79] , and how Internetbased treatment programs can support self-management of arthritis [80] , bone health, and persistent MSK pain for adults [81] and for young people [82] . Online resources such as painHEALTH (http://painhealth.csse.uwa.edu.au/) and the Pain Tool Kit (http://www.paintoolkit.org/), offer free 24/7 access to practical knowledge and skills to support best practice pain co-care. Social media tools are another key driver of engaged and empowered patients taking a greater role in their own health care [83, 84] . Furthermore, the use of mHealth applications is transforming the health landscape. Young people in particular, many of whom are 'digital natives'
indicate their preference for access to health services and resources is via eHealth and mHealth technologies [58] , although this is not necessarily universal [85] . While the evidence of effectiveness lags behind the application of technology to health, it 23 is clear that health systems will need to catch up, as technology continues to gain momentum. This rapid pace of change is exciting and creates new opportunities for better supporting implementation of MoCs across care settings and the life course, while concurrently highlighting the critical need for implementation science research in this nascent area.
Evaluating Models of Care for sustainable system reform Indeed, evaluation is a strategic priority of the Global Alliance for Musculoskeletal
Health. Evaluation approaches for MoCs can be considered as a hierarchy (Figure 2 Comparatively less work has been done at the systems level, largely because this level of evaluation requires significant resourcing contributions from administrative organisations, like Government, and evaluations take much longer to undertake and are inherently more complex. We suggest, however, that the impact and influence of system-wide or system-relevant evaluations are potentially far greater than component-level evaluations. Future evaluative work is therefore likely to be targeted more at the system level and will be facilitated through inter-agency partnership models and further accessibility to, and development of, linked data monitoring and data capture systems.
Figure 2
Evaluation hierarchy for Models of Care. The potential impact and influence of evaluation outcomes increases with higher evaluation levels.
Ensuring effective implementation: readiness and success
As global momentum builds in the development of MoCs for NCDs, there is an increasingly important rationale to; i) develop strategies to optimise development efforts to ensure successful implementation, and ii) to support a standardised approach to outcomes evaluation. This will enable comparisons between various
MoCs in order to generate a web of evidence meaningful to end users, and also allow the sharing and benchmarking of comparable outcomes between jurisdictions and/or nations.
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A recent, large qualitative study provides primary evidence concerning the critical importance of appropriate evaluation of MoCs to i) optimise the chances of successful and sustainable implementation ('readiness evaluation') and ii) deliver meaningful indicators of implementation success ('success evaluation') [86] .
Whereas the concept of success evaluation was well recognised and largely considered implicit as part of health system performance evaluation and quality improvement, the concept of readiness evaluation was considered far less well recognised. Readiness evaluation was found to be urgently needed, reflective of an appetite and expectation for deterministic and evaluative implementation approaches [92] . Further, these perceptions most likely reflect experiences of failed implementation beyond pilot studies and align with an emerging body of literature that now points to the need to assess organisational readiness for change in healthcare [37] . This is particularly so for chronic disease MoCs [94] , and particularly relevant in primary care settings where the majority of MSK healthcare is delivered [37] . This approach to readiness assessment is not a new concept. Indeed, it is entrenched in the business sector. Here, it is considered a standard approach to business improvement and change management [95] , embedded within contemporary implementation frameworks [92] and importantly, identified as a critical driver of evidence-practice gaps [37].
The need for outcomes (success) evaluation that considers consumer (i.e. patient as a workforce role change [96] , is important at a local service level, the broader system implications are not necessarily considered. Real cost calculations, undertaken retrospectively, are equally important for accurately assessing the status quo and observed trends prior to the introduction of system-level change: here the data may inform a rationale for change. A recent example is costing hospital care for osteoporotic fractures in Western Australia over the last 10 years, using linked data 28 systems [97] . Cost predictions at a systems level will also be critical to informing decisions about implementation of MoCs. For example, recent work by Ackerman et al [6] and Schofield et al [7] and based on the Arthritis, Diet and Activity Promotion Trial (ADAPT), estimated the health and broader economic benefits likely to be gained by implementation of a conservative care program for Australians with severe knee osteoarthritis [98] . [7] . These broader system implications have significant value to government when developing and iterating contemporary policy frameworks.
An internationally applicable approach to implementation
Recently, an internationally-applicable approach to the development and evaluation [74, 101] . The articulation between the Framework, MoCs and these other guiding resources is illustrated in Figure 3 . Further validating its components and use as a contemporary framework for evaluating development and implementation of MoCs, the Framework also aligns with contemporary generic implementation science frameworks [37, 53, 54] . 
System level factors Determinants of musculoskeletal (MSK) health

Macro
The macro level considers the functionality and scope of health systems or organisations, health policy, infrastructure and resource allocation, and socioeconomic factors. Health systems/organisations and their governance through health policy play a critical role in the planning and delivery of MSK healthcare for older people. Healthcare systems in developed nations are usually oriented towards acute care services and respond to mortality risk rather than longterm morbidity associated with MSK conditions and their co-morbidities which stymies opportunities for service development in ambulatory and primary care -arguably, the setting where MSK healthcare is most needed. Given the MSK conditions are less frequently associated with mortality, health systems and policy tend to be less responsive to these conditions and place lower importance on the development of policies and programmes to address them. This contributes to a general lack of population awareness concerning the burden an impact associated with MSK conditions. Further, access to MSK healthcare is variable according to geography, ethnicity and socioeconomic status, 33 thus creating care disparities [102] [103] [104] [105] [106] .
Meso
The meso level considers health services, the clinical workforce volume and competencies, health professional and student/trainee education, service delivery systems, funding models, and clinical infrastructure. Despite the identified burden of disease, the delivery of MSK care from practitioners and health systems inadequately aligns with best
available evidence for what works [23, 25] . This may be attributed, in part, to deficiencies in knowledge and skills of health professionals, but is also largely influenced by funding and service models that inadequately support effective co-care. Access to, and delivery of, care is further complicated by the chronicity of MSK conditions and the high prevalence of comorbid conditions, particularly mental health conditions.
Micro
The micro level refers to the participation by the person in their care. The extent to which people participate in their care is largely dependent on their health literacy as it relates navigating the health system and MSK health. While all clinical guidelines recommend self-management by consumers, implicit in this expectation is that consumers have the knowledge and skills to do so. In many cases, this may not be the case, particularly for those people who live in socioeconomic disadvantage or in rural and remote settings. It is critical, therefore, for meso-and macro-level systems and services to build capacity in people to effectively participate in the management of their MSK health condition(s).
